Clinical Trial Update: Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study evaluating modified DEP regimens for the treatment of hemophagocytic lymphohistiocytosis, with status not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Hemophagocytic Lymphohistiocytoses | Phase 4 | Status: NOT_YET_RECRUITING